KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $596 | -80.5% | 2,751 | -83.6% | 0.00% | -40.0% |
Q1 2023 | $3,051 | +104.4% | 16,800 | +121.1% | 0.01% | -28.6% |
Q4 2022 | $1,493 | -99.9% | 7,600 | -16.5% | 0.01% | -30.0% |
Q3 2022 | $2,046,000 | +252.2% | 9,100 | +97.8% | 0.01% | +233.3% |
Q2 2022 | $581,000 | +6.6% | 4,600 | +7.0% | 0.00% | +50.0% |
Q1 2022 | $545,000 | -3.2% | 4,300 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $563,000 | +7.0% | 4,300 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $526,000 | +7.3% | 4,300 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $490,000 | +4.7% | 4,300 | +10.3% | 0.00% | 0.0% |
Q1 2021 | $468,000 | +15.3% | 3,900 | -2.5% | 0.00% | 0.0% |
Q4 2020 | $406,000 | +31.4% | 4,000 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $309,000 | -30.6% | 4,000 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $445,000 | +129.4% | 4,000 | +48.1% | 0.00% | +100.0% |
Q1 2020 | $194,000 | +115.6% | 2,700 | +125.0% | 0.00% | – |
Q4 2019 | $90,000 | +136.8% | 1,200 | -50.0% | 0.00% | – |
Q3 2019 | $38,000 | – | 2,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |